Inovio Pharmaceuticals Inc (INO)
4.065
+0.10
(+2.39%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 18:10
Inovio Pharmaceuticals Max Drawdown (5Y): 98.90% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.90% |
| September 30, 2024 | 98.90% |
| August 31, 2024 | 98.90% |
| July 31, 2024 | 98.90% |
| June 30, 2024 | 98.90% |
| May 31, 2024 | 98.90% |
| April 30, 2024 | 98.90% |
| March 31, 2024 | 98.90% |
| February 29, 2024 | 98.90% |
| January 31, 2024 | 98.90% |
| December 31, 2023 | 98.90% |
| November 30, 2023 | 98.90% |
| October 31, 2023 | 98.87% |
| September 30, 2023 | 98.82% |
| August 31, 2023 | 98.78% |
| July 31, 2023 | 98.78% |
| June 30, 2023 | 98.78% |
| May 31, 2023 | 98.14% |
| April 30, 2023 | 97.80% |
| March 31, 2023 | 97.50% |
| February 28, 2023 | 96.09% |
| January 31, 2023 | 95.55% |
| December 31, 2022 | 95.55% |
| November 30, 2022 | 95.46% |
| October 31, 2022 | 95.46% |
| Date | Value |
|---|---|
| September 30, 2022 | 95.46% |
| August 31, 2022 | 95.46% |
| July 31, 2022 | 95.46% |
| June 30, 2022 | 95.46% |
| May 31, 2022 | 94.54% |
| April 30, 2022 | 91.39% |
| March 31, 2022 | 90.63% |
| February 28, 2022 | 90.63% |
| January 31, 2022 | 88.26% |
| December 31, 2021 | 84.25% |
| November 30, 2021 | 84.00% |
| October 31, 2021 | 84.00% |
| September 30, 2021 | 84.00% |
| August 31, 2021 | 84.00% |
| July 31, 2021 | 84.00% |
| June 30, 2021 | 84.00% |
| May 31, 2021 | 84.00% |
| April 30, 2021 | 84.00% |
| March 31, 2021 | 84.00% |
| February 28, 2021 | 84.00% |
| January 31, 2021 | 84.00% |
| December 31, 2020 | 84.00% |
| November 30, 2020 | 84.00% |
| October 31, 2020 | 84.00% |
| September 30, 2020 | 84.00% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
84.00%
Minimum
Nov 2019
98.90%
Maximum
Nov 2023
91.23%
Average
92.96%
Median
Max Drawdown (5Y) Benchmarks
| Novavax Inc | 98.82% |
| Baxter International Inc | 64.18% |
| AIM ImmunoTech Inc | 99.76% |
| Protalix BioTherapeutics Inc | 94.38% |
| Armata Pharmaceuticals Inc | 99.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -40.19 |
| Beta (5Y) | 0.8346 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 115.0% |
| Historical Sharpe Ratio (5Y) | -0.2558 |
| Historical Sortino (5Y) | -0.7505 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 35.49% |